Nektar Therapeutics Common Stock — Institutional Ownership

Which tracked institutions hold NKTR, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

19
Funds holding
$170480968
Total value held
Buying
16 added/new · 3 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $49836168 692650 +47043 +7.29%
2 Morgan Stanley $47442895 659387 +92966 +16.41%
3 Invesco Ltd. $19793774 468159 +241262 +106.33%
4 State Street Corp $17608108 244727 +49071 +25.08%
5 Ameriprise Financial Inc $9837702 136730 NEW BUY
6 Goldman Sachs Group Inc $9133477 126942 -20851 -14.11%
7 Northern Trust Corp $5655126 78598 +22522 +40.16%
8 Bank Of America Corp /De/ $4242028 58958 +32866 +125.96%
9 Barclays Plc $2328013 32356 NEW BUY
10 Citigroup Inc $1512652 35777 +32730 +1074.17%
11 Royal Bank Of Canada $1164000 16181 NEW BUY
12 Janus Henderson Group Plc $771093 10729 NEW BUY
13 Bank Of New York Mellon Corp $474686 6597 NEW BUY
14 Sei Investments Co $321688 4471 NEW BUY
15 Raymond James Financial Inc $212468 2953 NEW BUY
16 Us Bancorp \De\ $137856 1916 +656 +52.06%
17 Wells Fargo & Company/Mn $8076 191 -57 -22.98%
18 Wealthfront Corp $703 11532 -928 -7.45%
19 Amalgamated Financial Corp. $455 84491 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.